Boucher Kelley

Apellis Pharmaceuticals, Inc. · Chief People Officer

Boucher Kelley is listed in public filings as officer: Chief People Officer. This Boucher Kelley insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Apellis Pharmaceuticals, Inc. (APLS). Investors use Boucher Kelley's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Apellis Pharmaceuticals, Inc.APLS$067.4k sharesOtherMay 14, 2026$1.3M67.4k shares$19.39--
Apellis Pharmaceuticals, Inc.APLS$045.8k sharesOtherMay 14, 2026$1.3M45.8k shares$28.17--
Apellis Pharmaceuticals, Inc.APLS$033k sharesOtherMay 14, 2026$554.0K33k shares$16.80--
Apellis Pharmaceuticals, Inc.APLS$0127.8k sharesOtherMay 14, 2026$13127.8k shares$0.0001--
Apellis Pharmaceuticals, Inc.APLS--30.1k sharesOtherMay 14, 2026Disclosure amount unavailable30.1k shares----
Apellis Pharmaceuticals, Inc.APLS--15.1k sharesGrant / ExerciseMay 14, 2026Disclosure amount unavailable15.1k shares----
Apellis Pharmaceuticals, Inc.APLS--30.1k sharesGrant / ExerciseMay 14, 2026Disclosure amount unavailable30.1k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Apellis Pharmaceuticals, Inc.APLS--127.8k sharesGrant / ExerciseJan 28, 2026Disclosure amount unavailable30.1k shares----
Apellis Pharmaceuticals, Inc.APLS$1.3M45.8k sharesGrant / ExerciseSep 2, 2025$1.3M45.8k shares$28.17--
Apellis Pharmaceuticals, Inc.APLS--97.7k sharesGrant / ExerciseSep 2, 2025Disclosure amount unavailable30.5k shares----
Apellis Pharmaceuticals, Inc.APLS$1.3M67.4k sharesGrant / ExerciseJun 9, 2025$1.3M67.4k shares$19.39--
Apellis Pharmaceuticals, Inc.APLS--67.2k sharesGrant / ExerciseJun 9, 2025Disclosure amount unavailable45.1k shares----
Apellis Pharmaceuticals, Inc.APLS$554k33k sharesGrant / ExerciseMay 28, 2025$554.0K33k shares$16.80--
Apellis Pharmaceuticals, Inc.APLS--22.1k sharesGrant / ExerciseMay 28, 2025Disclosure amount unavailable22.1k shares----